Literature DB >> 26613731

Tumour budding in colorectal cancer: what do we know and what can we do?

Linde De Smedt1, Sofie Palmans1, Xavier Sagaert2,3.   

Abstract

Budding is a process during which individual or small clusters of up to five tumour cells detach from the main tumour mass and invade into the surrounding stroma. In colorectal cancer, this feature is observed in 20-40% of cases and is associated with lymphovascular invasion, lymph node and distant metastases, and poor prognosis. A variety of scoring systems for budding have been proposed but so far a gold standard is lacking, hampering implementation of a budding score in guidelines for pathological examination of colorectal cancer. Furthermore, little is known about the mechanisms which cause tumour cells to detach from the main tumour mass and obtain increased invasive potential. In this review, we present an overview of tumour budding including its definition, scoring systems, prognostic relevance and biological mechanisms involved.

Entities:  

Keywords:  Budding; Colorectal cancer; Epithelial-mesenchymal transition; Metastasis

Mesh:

Year:  2015        PMID: 26613731     DOI: 10.1007/s00428-015-1886-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  79 in total

1.  Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.

Authors:  Lindsay J Talbot; Syamal D Bhattacharya; Paul C Kuo
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

2.  Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.

Authors:  Inti Zlobec; Parham Minoo; Luigi Terracciano; Kristi Baker; Alessandro Lugli
Journal:  Histopathology       Date:  2011-09       Impact factor: 5.087

3.  Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma.

Authors:  José García-Solano; Pablo Conesa-Zamora; Javier Trujillo-Santos; Daniel Torres-Moreno; Markus J Mäkinen; Miguel Pérez-Guillermo
Journal:  Hum Pathol       Date:  2011-12-29       Impact factor: 3.466

4.  Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.

Authors:  Huann-Sheng Wang; Wen-Yih Liang; Tzu-Chen Lin; Wei-Shone Chen; Jeng-Kae Jiang; Shung-Haur Yang; Shih-Ching Chang; Jen-Kou Lin
Journal:  Dis Colon Rectum       Date:  2005-06       Impact factor: 4.585

Review 5.  Evolution of colorectal cancer: change of pace and change of direction.

Authors:  Jereny R Jass; Joanne Young; Barbara A Leggett
Journal:  J Gastroenterol Hepatol       Date:  2002-01       Impact factor: 4.029

6.  Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Authors:  H Ueno; J Murphy; J R Jass; H Mochizuki; I C Talbot
Journal:  Histopathology       Date:  2002-02       Impact factor: 5.087

7.  Prognostic value of tumor "budding" in patients with colorectal cancer.

Authors:  K Hase; C Shatney; D Johnson; M Trollope; M Vierra
Journal:  Dis Colon Rectum       Date:  1993-07       Impact factor: 4.585

8.  β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis.

Authors:  Zhigang Chen; Xin He; Minyue Jia; Yang Liu; Dihong Qu; Dang Wu; Pin Wu; Chao Ni; Zhigang Zhang; Jun Ye; Jinghong Xu; Jian Huang
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

9.  Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients.

Authors:  I Zlobec; M Hädrich; H Dawson; V H Koelzer; M Borner; M Mallaev; B Schnüriger; D Inderbitzin; A Lugli
Journal:  Br J Cancer       Date:  2013-12-24       Impact factor: 7.640

10.  Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer.

Authors:  Peter D Caie; Arran K Turnbull; Susan M Farrington; Anca Oniscu; David J Harrison
Journal:  J Transl Med       Date:  2014-06-01       Impact factor: 5.531

View more
  25 in total

1.  Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.

Authors:  Han-Na Kim; Soo Yeon Lee; Baek-Hui Kim; Chung-Yeul Kim; Aeree Kim; Hayeon Kim
Journal:  Virchows Arch       Date:  2021-01-04       Impact factor: 4.064

Review 2.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

Authors:  Alessandro Lugli; Richard Kirsch; Yoichi Ajioka; Fred Bosman; Gieri Cathomas; Heather Dawson; Hala El Zimaity; Jean-François Fléjou; Tine Plato Hansen; Arndt Hartmann; Sanjay Kakar; Cord Langner; Iris Nagtegaal; Giacomo Puppa; Robert Riddell; Ari Ristimäki; Kieran Sheahan; Thomas Smyrk; Kenichi Sugihara; Benoît Terris; Hideki Ueno; Michael Vieth; Inti Zlobec; Phil Quirke
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

3.  Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer.

Authors:  Kazuyuki Saito; Takashi Okuyama; Shunya Miyazaki; Haruka Oi; Takashi Mitsui; Takuji Noro; Emiko Takeshita; Yuko Ono; Taizen Urahashi; Hidehiro Tajima; Hideyuki Yoshitomi
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

4.  Value of a Signature of Immune-Related Genes in Predicting the Prognosis of Melanoma and Its Responses to Immune Checkpoint Blocker Therapies.

Authors:  Bo Yuan; Linlin Miao; Disen Mei; Lingzhi Li; Qiongyan Zhou; Dong Dong; Songting Wang; Xiaoxia Zhu; Suling Xu
Journal:  Comput Math Methods Med       Date:  2022-06-20       Impact factor: 2.809

5.  Tumor cell-secreted exosomal miR-22-3p inhibits transgelin and induces vascular abnormalization to promote tumor budding.

Authors:  Yaju Feng; Lumeng Wang; Ting Wang; Ying Li; Qingqing Xun; Renya Zhang; Lin Liu; Lei Li; Wei Wang; Yixuan Tian; Lili Yang; Xiao Zhi; Bijiao Zhou; Xin Chen; Tao Sun; Yanrong Liu
Journal:  Mol Ther       Date:  2021-02-10       Impact factor: 12.910

Review 6.  Tumor Budding: The Name is EMT. Partial EMT.

Authors:  Alexandru Dan Grigore; Mohit Kumar Jolly; Dongya Jia; Mary C Farach-Carson; Herbert Levine
Journal:  J Clin Med       Date:  2016-04-29       Impact factor: 4.241

7.  Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.

Authors:  Edita Baltruskeviciene; Diana Schveigert; Vaidotas Stankevicius; Ugnius Mickys; Tadas Zvirblis; Jaroslav Bublevic; Kestutis Suziedelis; Eduardas Aleknavicius
Journal:  BMC Cancer       Date:  2017-09-01       Impact factor: 4.430

8.  MicroRNA-200b is downregulated in colon cancer budding cells.

Authors:  Kirsten Nguyen Knudsen; Jan Lindebjerg; Boye Schnack Nielsen; Torben Frøstrup Hansen; Flemming Brandt Sørensen
Journal:  PLoS One       Date:  2017-05-26       Impact factor: 3.240

9.  A Case of Colonic Micropapillary Carcinoma with a High Frequency of Apoptosis.

Authors:  Kazumori Arai; Tomohiro Iwasaki; Hisato Ishimatsu; Chinatsu Tsuchiya; Aki Kubota; Akihiro Sonoda; Ko Ohata
Journal:  J Gastrointest Cancer       Date:  2021-07-24

10.  Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact.

Authors:  Hidehiko Takigawa; Yasuhiko Kitadai; Kei Shinagawa; Ryo Yuge; Yukihito Higashi; Shinji Tanaka; Wataru Yasui; Kazuaki Chayama
Journal:  Neoplasia       Date:  2017-04-20       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.